Physician

Angelos Koutsonikolis

According to 2025 Medicare claims, Angelos Koutsonikolis (NPI: 1295847978) practices allergy/immunology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is ANGELOS KOUTSONIKOLIS MD PA (NPI: 1366639262; TIN: 202221113) and primary practice location at 33437-3532.

Koutsonikolis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 504 traditional Medicare patients, billed 46,771 HCPCS/CPT codes, and received $950,889 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,386 prescription claims across 461 beneficiaries totaling $464,049 in drug costs, led by Xolair (Omalizumab). DME data shows 110 claims. Open Payments data shows 5 records totaling $99. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $331,049 to $950,889. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $163,774 to $464,049. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,818 and ending at $2,397.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	343	23,336	$331,049
2016	376	25,749	$363,810
2017	426	28,316	$414,117
2018	443	32,128	$521,440
2019	441	33,553	$587,568
2020	450	43,648	$805,473
2021	479	41,945	$775,227
2022	479	43,031	$837,115
2023	485	47,021	$939,423
2024	504	46,771	$950,889

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	274	1,490	$163,774
2016	271	1,561	$244,103
2017	296	1,678	$303,525
2018	318	1,680	$362,714
2019	340	1,685	$514,264
2020	375	1,959	$517,331
2021	415	2,161	$487,297
2022	391	2,243	$534,747
2023	416	2,199	$513,170
2024	461	2,386	$464,049

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	113	$63,300
2016	N/R	80	$112,909
2017	N/R	125	$164,161
2018	N/R	177	$168,863
2019	N/R	139	$123,683
2020	N/R	137	$187,415
2021	N/R	144	$211,297
2022	N/R	89	$145,008
2023	N/R	108	$168,127
2024	N/R	110	$181,173

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	158	158	$143
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	250	463	$108
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	209	616	$77
95165	Professional service for preparation and provision of 1 or more antigens	162	5,160	$13
95117	Professional service for multiple injections of allergen	164	3,910	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xolair	Omalizumab	47	1,316	$115,333
Nucala	Mepolizumab	23	644	$88,079
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	72	3,360	$71,401
Breo Ellipta	Fluticasone/Vilanterol	72	2,940	$37,362
Ipratropium Bromide	Ipratropium Bromide	235	7,267	$10,215

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	12	$73,530
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	13	$62,598
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	N	N/R	12	$21,420
J1568	Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg	N	N/R	12	$17,839
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	11	$3,626

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$99	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Angelos Koutsonikolis?

Tedicare shows public-source Medicare data for Angelos Koutsonikolis (NPI 1295847978), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Angelos Koutsonikolis have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Angelos Koutsonikolis?

Angelos Koutsonikolis is linked to ANGELOS KOUTSONIKOLIS MD PA (billing NPI 1366639262) in the available physician profile data.

Does Angelos Koutsonikolis have Open Payments data?

Angelos Koutsonikolis has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.